Cargando…
Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts
Oncolytic adenoviruses (OAds) are increasingly recognized as vectors for immunotherapy in the treatment of various solid tumors. The myriads of advantages of using adenovirus include targeted specificity upon infection and selective replication, which lead to localized viral burst, exponential sprea...
Autores principales: | Huang, Jing Li, LaRocca, Christopher J., Yamamoto, Masato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344254/ https://www.ncbi.nlm.nih.gov/pubmed/28536390 http://dx.doi.org/10.3390/biomedicines4030023 |
Ejemplares similares
-
Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer
por: Salzwedel, Amanda O., et al.
Publicado: (2018) -
428 Development of an Oncolytic Adenovirus to Treat Metastatic Colorectal Cancer
por: LaRocca, Christopher J., et al.
Publicado: (2023) -
Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination
por: Sato-Dahlman, Mizuho, et al.
Publicado: (2020) -
Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity
por: Hajeri, Praveensingh B., et al.
Publicado: (2020) -
Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles
por: Loskog, Angelica
Publicado: (2015)